A-01 Registration at the conference venue Tuesday 18:30-20:00 |
A-02 Opening ceremony and welcome reception Tuesday 20:30-22:30 |
B-01 Registration at the conference venue Wednesday 08:00-08:45 |
B-02 Welcome and Introduction Wednesday 08:45-09:00 |
B-03 Amin Rostami OrBiTo - translating mechanistic knowledge on absorption into predictive models Wednesday 09:00-09:40 |
B-04 Benjamin Guiastrennec Mechanism-based modelling of gastric emptying and bile release in response to caloric intake Wednesday 09:40-10:00 |
B-05 Andrés Olivares-Morales An in silico physiologically-based pharmacokinetic (PBPK) study of the impact of the drug release rate on oral absorption, gut wall metabolism and relative bioavailability Wednesday 10:00-10:20 |
B-06 Coffee break, poster and software session I: posters in Group I (with poster numbers starting with I-) are accompanied by their presenter Wednesday 10:20-11:50 |
B-07 Kapil Gadkar Development of Virtual Population for a Quantitative Systems Pharmacology model Wednesday 11:50-12:10 |
B-08 Maciej Swat PharmML 1.0 - An Exchange Standard for Models in Pharmacometrics Wednesday 12:10-12:30 |
B-09 Marc Gastonguay Proposal for a Web-Based Open Pharmacometrics Curriculum Wednesday 12:30-12:40 |
B-10 Lunch Wednesday 12:40-14:10 |
B-11 Pierre Marquet Model-based personalized medicine in transplantation Wednesday 14:10-14:50 |
B-12 Núria Buil Bruna A step forward toward personalised medicine in oncology: Population modelling for the early prediction of disease progression using biomarkers Wednesday 14:50-15:10 |
B-13 Tea break, poster and software session II: posters in Group II (with poster numbers starting with II-) are accompanied by their presenter Wednesday 15:10-16:30 |
B-14 Julia Korell Application of a model based longitudinal network meta-analysis of FEV1 in COPD trials in clinical drug development Wednesday 16:30-16:50 |
B-15 Sebastian Weber Bayesian Drug Disease Model with Stan - Using published longitudinal data summaries in population models Wednesday 16:50-17:10 |
B-16 Angelica Quartino An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer's Disease Wednesday 17:10-17:30 |
B-17 Yaming Hang Pharmacokinetic and Pharmacodynamic Analysis of Longitudinal Gd-Enhanced Lesion Count in Subjects with Relapsing Remitting Multiple Sclerosis Treated with Peginterferon beta-1a Wednesday 17:30-17:50 |
C-01 Tram Nguyen Handling data below the quantification limit in viral kinetic modeling for model evaluation and prediction of treatment outcome Thursday 08:45-09:10 |
C-02 Nikolaos Tsamandouras Development of population based approaches to describe the complex pharmacokinetics of simvastatin in different individuals. Bridging the gap between population and physiologically based pharmacokinetic modelling. Thursday 09:10-09:35 |
C-03 Mélanie Wilbaux A dynamic K-PD joint model for the kinetics of CTC (Circulating Tumor Cell) count and PSA concentration during treatment in metastatic castration-resistant prostate cancer Thursday 09:35-10:00 |
C-04 Presentation of Lewis Sheiner student session awards Thursday 10:00-10:05 |
C-05 Coffee break, poster and software session III: posters in Group III (with poster numbers starting with III-) are accompanied by their presenter Thursday 10:05-11:30 |
C-06 Scott Marshall Good Practices in Model Informed Drug Discovery and Development (MID3): Practice, Application, Documentation and Reporting Thursday 11:30-11:50 |
C-07 Terry Shepard How European Regulators are Facilitating the Use of Modelling and Simulation: MSWG History, Activity and Future Thursday 11:50-12:15 |
C-08 Efthymios Manolis EMA qualification of novel methodologies: are we ready for M&S ? Thursday 12:15-12:35 |
C-09 Panel discussion Thursday 12:35-12:50 |
C-10 Lunch Thursday 12:50-14:15 |
C-11 Björn Bornkamp The MCP-Mod methodology - A statistical methodology for dose-response Thursday 14:15-14:40 |
C-12 Vikram Sinha The Role of Model Based Drug Development – Is it time to repaint the canvas? Thursday 14:40-15:15 |
C-13 Tea break, poster and software session IV: posters in Group IV (with poster numbers starting with IV-) are accompanied by their presenter Thursday 15:15-16:40 |
C-14 Camille Vong In silico comparison of MTD determination in a phase I dose-finding framework Thursday 16:40-17:00 |
C-15 Coen van Hasselt Towards early integrated mechanism-based prediction of clinical outcome and cost-effectiveness in castration-resistant prostate cancer Thursday 17:00-17:20 |
D-01 Edouard Ollier Group comparison with fused lasso penalized likelihood: an alternative to test based methods Friday 09:00-09:20 |
D-02 Elin Svensson Prediction of pharmacokinetic interactions for drugs with a long half-life - evidence for the need of model-based analysis Friday 09:40-09:40 |
D-03 Yasunori Aoki Averaged Model Based Decision Making for Dose Selection Studies Friday 09:40-10:00 |
D-04 Preview of PAGE2015 Friday 10:00-10:10 |
D-05 Coffee break Friday 10:10-10:50 |
D-06 Sharon Hori Modeling cancer blood biomarker dynamics in relation to tumor growth Friday 10:50-11:10 |
D-07 Rik de Greef Modeling of tumor size reduction patterns in advanced melanoma under treatment with MK-3475, a potent antibody against PD-1 Friday 11:10-11:30 |
D-08 Pauline Mazzocco A mixed-effect modeling framework to personalize treatment of low-grade glioma patients Friday 11:30-11:50 |
D-09 Nick Holford Power and Type 1 Error of Tumour Size Metrics Used to Predict Survival Friday 11:50-12:10 |
D-10 Closing remarks Friday 12:10-12:20 |
D-11 Audience input for potential PAGE2015 topics Friday 12:20-12:40 |